Clemastine alleviates cognitive dysfunction after SAH by targeting neuronal CNTN1 to regulate the ADA-adenosine pathway. - Li LX; Wei BY; Jin L; Wu Y; Yang ZY; Li C; Zhou JM; Song Y; Gong WZ; Ou-Yang YH; Huang H; Feng X; et al. (Acta pharmacologica Sinica, 2026)